
Concentrate your efforts on delivering outstanding, data-informed care using Valant, the comprehensive EHR and practice management solution specifically crafted for behavioral health practices, regardless of their size. Valant is designed to enable you to minimize the time spent on administrative duties, allowing for more focus on providing high-quality care to both individuals and groups.
Streamline your workflow by:
- Alleviating documentation burdens with a system that automatically creates clinical narratives, nearly finishing your notes for you.
- Scheduling over 80 integrated, reportable outcome measures to be sent to patients automatically via the MYIO Patient Portal prior to their appointments.
- Allowing the system to generate a coded charge when you document appointments.
- Automating the patient onboarding experience so intake packets are readily available for patients to sign within their portal.
- Receiving service requests directly through your EHR, effectively managing new patient inquiries, and obtaining a data-driven match score for prospective patients, thereby enhancing your practice's efficiency and patient satisfaction.
Learn more
Elation Health stands out as the premier platform for primary care, enabling 32,000 healthcare providers to offer tailored care to more than 16 million patients. By utilizing a clinically-focused electronic health record system, along with integrated billing solutions and AI-driven tools, Elation enhances care processes, ensuring that independent practices can flourish in a competitive landscape. This commitment to innovation not only improves patient outcomes but also streamlines operations for practitioners.
Learn more
Progeny Clinical
Discover our advanced screening tools aimed at pinpointing patients who are at elevated risk for breast, colorectal, and various other cancers. Progeny Clinical enhances the management of family histories, risk evaluations, and treatment alternatives for your patients. You can collect family history data online and automatically generate pedigrees before the clinic visit. Existing pedigrees can be modified or new ones created at any moment to reflect the most accurate information. With just a single click, you can implement validated hereditary cancer risk assessment models, thereby eliminating the need for data re-entry. Streamline genetic testing by ordering it through Ambry Genetics for added convenience. You can monitor and evaluate results from any lab without leaving the software, which improves overall workflow. Additionally, you can produce letters, consultation notes, reports, and documents effortlessly using customized templates with integrated patient data fields. Take advantage of pre-configured or personalized data input screens to quickly generate custom queries and spreadsheet reports. Furthermore, you have the option to embed a hyperlink within your electronic medical records that leads directly to the patient’s most recent pedigree. This innovative strategy not only saves valuable time but also significantly enhances patient care and optimizes workflow efficiency, ultimately leading to better healthcare outcomes.
Learn more
Genomenon
Pharmaceutical firms need a wealth of genomic information to successfully execute precision medicine strategies; however, they often utilize only a fraction—around 10%—of the total data at their disposal for decision-making. Genomenon offers an extensive database to counter this limitation. Their Prodigy™ Patient Landscapes deliver a cost-effective and efficient approach for conducting natural history research, which is crucial for developing treatments for rare conditions by expanding the understanding of both past and future health data. Employing a sophisticated AI-driven process, Genomenon meticulously analyzes each patient referenced in the medical literature much faster than traditional methods. It is essential to capture all pertinent insights by examining every genomic biomarker highlighted in scholarly articles. Each scientific assertion is backed by solid evidence sourced from medical literature, enabling researchers to identify all genetic factors and pinpoint variants classified as pathogenic according to ACMG clinical criteria, thus streamlining the creation of targeted therapies. By adopting this thorough strategy, pharmaceutical companies can significantly boost their research efficiency and, in turn, enhance patient outcomes. This innovative model not only fosters advancements in drug development but also contributes to a deeper understanding of genetic influences on health.
Learn more